Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|26|2860-2886

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.26, 2017-09, pp. : 2860-2886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans

By  

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 665-682

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Schistosome Histone Modifying Enzymes for Drug Development

By  

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3567-3578

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance

By  

Current Medicinal Chemistry, Vol. 21, Iss. 14, 2014-01 ,pp. : 1618-1630

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 853-864

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics in Drug-Metabolizing Enzymes Catalyzing Anticancer Drugs for Personalized Cancer Chemotherapy

By  

Current Drug Metabolism, Vol. 8, Iss. 6, 2007-08 ,pp. : 554-562

Bentham Science Publishers

Access to resources Recommend Favorite